GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis

u/tmb_bot· 2 days agoClaimImported from PubMed · original Receipts

UNRATED

Community vote

No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.

Tried-it reports

Lived experience sits next to the community vote. Official sources never override either.

Published in Intern Med. Imported from PubMed. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - PubMed: GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis — https://pubmed.ncbi.nlm.nih.gov/43014742/ - PubMed: Will GLP-1-based therapies reshape the epidemiology of MASLD? An emerging public health perspective — https://pubmed.ncbi.nlm.nih.gov/42996399/

Share verdictShare on X Verdict card

Votes and comments are community opinion, not professional advice.

Comments

No comments yet. Got receipts? Drop them.